These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 17010805)

  • 1. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Qiu X; Liu W; Hu D; Zhu T; Li C; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Zhang L
    Am J Cardiol; 2009 May; 103(10):1439-44. PubMed ID: 19427443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study.
    Bhuiyan ZA; Jongbloed JD; van der Smagt J; Lombardi PM; Wiesfeld AC; Nelen M; Schouten M; Jongbloed R; Cox MG; van Wolferen M; Rodriguez LM; van Gelder IC; Bikker H; Suurmeijer AJ; van den Berg MP; Mannens MM; Hauer RN; Wilde AA; van Tintelen JP
    Circ Cardiovasc Genet; 2009 Oct; 2(5):418-27. PubMed ID: 20031616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
    Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy.
    Lahtinen AM; Lehtonen A; Kaartinen M; Toivonen L; Swan H; Widén E; Lehtonen E; Lehto VP; Kontula K
    Int J Cardiol; 2008 May; 126(1):92-100. PubMed ID: 17521752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteria.
    Cox MG; van der Smagt JJ; Noorman M; Wiesfeld AC; Volders PG; van Langen IM; Atsma DE; Dooijes D; Houweling AC; Loh P; Jordaens L; Arens Y; Cramer MJ; Doevendans PA; van Tintelen JP; Wilde AA; Hauer RN
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):126-33. PubMed ID: 20215590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis.
    Antoniades L; Tsatsopoulou A; Anastasakis A; Syrris P; Asimaki A; Panagiotakos D; Zambartas C; Stefanadis C; McKenna WJ; Protonotarios N
    Eur Heart J; 2006 Sep; 27(18):2208-16. PubMed ID: 16893920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Cox MG; van der Smagt JJ; Wilde AA; Wiesfeld AC; Atsma DE; Nelen MR; Rodriguez LM; Loh P; Cramer MJ; Doevendans PA; van Tintelen JP; de Bakker JM; Hauer RN
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):524-30. PubMed ID: 19843920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutation.
    van der Smagt JJ; van der Zwaag PA; van Tintelen JP; Cox MG; Wilde AA; van Langen IM; Ummels A; Hennekam FA; Dooijes D; Gerbens F; Bikker H; Hauer RN; Doevendans PA
    Cardiology; 2012; 123(3):181-9. PubMed ID: 23147395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
    Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
    Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel plakophilin2 mutation: three-generation family with arrhythmogenic right ventricular cardiomyopathy.
    Aneq MÅ; Fluur C; Rehnberg M; Söderkvist P; Engvall J; Nylander E; Gunnarsson C
    Scand Cardiovasc J; 2012 Apr; 46(2):72-5. PubMed ID: 22035158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
    Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study.
    Tandri H; Macedo R; Calkins H; Marcus F; Cannom D; Scheinman M; Daubert J; Estes M; Wilber D; Talajic M; Duff H; Krahn A; Sweeney M; Garan H; Bluemke DA;
    Am Heart J; 2008 Jan; 155(1):147-53. PubMed ID: 18082506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial form of arrhythmogenic right ventricular cardiomyopathy.
    Włodarska EK; Konka M; Kepski R; Zaleska T; Płoski R; Ruzyłło W; Janion M; Jaworska K; Rydlewska-Sadowska W; Hoffman P
    Kardiol Pol; 2004 Jan; 60(1):1-14. PubMed ID: 15004627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.
    Bhonsale A; Groeneweg JA; James CA; Dooijes D; Tichnell C; Jongbloed JD; Murray B; te Riele AS; van den Berg MP; Bikker H; Atsma DE; de Groot NM; Houweling AC; van der Heijden JF; Russell SD; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Calkins H; Hauer RN
    Eur Heart J; 2015 Apr; 36(14):847-55. PubMed ID: 25616645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Smith W;
    Heart Lung Circ; 2011 Dec; 20(12):757-60. PubMed ID: 21885338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice.
    Fressart V; Duthoit G; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Dubourg O; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller D; Hidden-Lucet F; Simon F; Bessirard V; Roux-Buisson N; Hebert JL; Azarine A; Casset-Senon D; Rouzet F; Lecarpentier Y; Fontaine G; Coirault C; Frank R; Hainque B; Charron P
    Europace; 2010 Jun; 12(6):861-8. PubMed ID: 20400443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers.
    Groeneweg JA; van der Zwaag PA; Olde Nordkamp LR; Bikker H; Jongbloed JD; Jongbloed R; Wiesfeld AC; Cox MG; van der Heijden JF; Atsma DE; de Boer K; Doevendans PA; Vink A; van Veen TA; Dooijes D; van den Berg MP; Wilde AA; van Tintelen JP; Hauer RN
    Am J Cardiol; 2013 Oct; 112(8):1197-206. PubMed ID: 23871674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.